Results 51 to 60 of about 58,257 (152)

Efficacy and safety of topical oxymetazoline cream 1.0% for the treatment of facial erythema associated with rosacea: Findings from the second of 2 pivotal trials

open access: yes, 2017
Introduction: A phase 3 pivotal trial examined the efficacy and safety of oxymetazoline, a specific α1A-adrenoceptor agonist, for treatment of moderate to severe persistent facial erythema associated with rosacea.
Kaufman, Joely   +6 more
core   +1 more source

Role of Topical Oxymetazoline for Management of Erythematotelangiectatic Rosacea

open access: yes, 2017
Objective: To review and summarize topical oxymetazoline’s pharmacology, pharmacokinetics, efficacy, safety, cost, and place in therapy for persistent redness associated with erythematotelangiectatic rosacea. Data Sources: Literature searches of MEDLINE
John Erramouspe, Rebecca M. Hoover
core   +1 more source

How Does Oxymetazoline Change Nasal Aerodynamics and Symptomatology in Patients with Turbinate Hypertrophy?

open access: yesThe Laryngoscope, Volume 134, Issue 3, Page 1100-1106, March 2024.
This single‐blinded, longitudinal, prospective cohort study showed that while oxymetazoline broadly affects the entire length of the inferior and middle turbinates, its symptomatic improvement appears to be driven more by global nasal resistance and regional airflow properties, especially near the head of the inferior turbinate.
Zachary T. Root   +8 more
wiley   +1 more source

Xylometazoline and oxymetazoline - unusual effects of everyday drugs (literature review) [PDF]

open access: yes, 2021
Klas Jakub, Kluz Natalia, Piwowar Klaudia. Xylometazoline and oxymetazoline - unusual effects of everyday drugs (literature review). Journal of Education, Health and Sport. 2021;11(9):272-281. eISSN 2391-8306.
Klas, Jakub   +2 more
core  

Polymorphic study of pharmaceutically active ingredients (bosentan and oxymetazoline hydrochloride) under different conditions of crystallization and heat treatment

open access: yes, 2020
El polimorfismo farmaceutico, es la capacidad que tienen los ingredientes farmacéuticamente activos (IFA) en adoptar diferentes estructuras cristalinas lo que conlleva a cambios en las propiedades fisicoquímicas.
Serrano Castaño, Katherin Vanessa
core   +1 more source

Topical Oxymetazoline (Rhofade) in Rosacea

open access: yes, 2020
By definition, a drug is a medicine or substance that exerts a physiologic effect on an organism. In dermatology, various medications and substances are utilized on a daily basis, ranging from topical treatments to anesthetics in micrographic surgery ...
Nicole K. Nagrani   +9 more
core   +1 more source

Indirect Spectrophotometric Determination of Oxymetazoline Hydrochloride [PDF]

open access: yesRafidain Journal of Science, 2013
null Nabeel S. Othman   +1 more
openaire   +1 more source

Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion

open access: yes, 2010
Rationale: Chronic use of intranasal decongestants, such as oxymetazoline, leads to tachyphylaxis of response and rebound congestion, caused by a-adrenoceptor mediated down-regulation and desensitization of response.Objectives: We evaluated if ...
Khan, Faisel; id_orcid   +9 more
core   +1 more source

The stability of oxymetazoline hydrochloride in aqueous solution.

open access: yesActa poloniae pharmaceutica, 2002
The kinetics of the hydrolysis reaction of oxymetazoline hydrochloride in aqueous solution at three temperatures (343 K, 353 K, 363 K), over the pH-range 0.5-12.5 and ionic strength 0.5 has been investigated. The changes of concentration of oxymetazoline hydrochloride were followed by the HPLC method with UV detection.
openaire   +1 more source

Premedication Methods in Nasal Endoscopy: A Prospective, Randomized, Double-Blind Study [PDF]

open access: yes, 2017
Objectives To identify the optimal pharmacological method of preparing patients for nasal endoscopy. Methods Twenty healthy volunteers were enrolled in this prospective, randomized, double-blind study.
Kerem Kökoğlu   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy